The U.S. Food and Drug Administration (FDA) today announced that companies marketing unapproved ophthalmic balanced salt solutions (BSS) and unapproved topical drug products containing papain must ...
It appears that the FDA is requiring certain manufacturers of balanced salt solutions (BSS) to cease and desist from manufacturing these products on or before November 24, 2008. You can read the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback